Capricor Therapeutics Inc
CAPR
$6.71-7.70%
End of day · as of Oct 18, 2026, 12:45 PM ET
Mkt cap
$1.62B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-2.45
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Use this CAPR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CAPR income, balance, and cash tables.
Capricor Therapeutics Inc (CAPR) is a biotechnology company in the Healthcare sector.
Latest cached Capricor Therapeutics Inc (CAPR) net income for Dec 31, 2025 was -$105.0M. Statements: https://lician.com/financials/capr
Capricor Therapeutics Inc (CAPR) market capitalization is $1.62B on the latest cached snapshot.
Capricor Therapeutics Inc (CAPR) cached previous close $7.27; day range $6.71 – $7.21; volume 1,920,023. Session quote: https://lician.com/quote/capr
Capricor Therapeutics Inc (CAPR) latest cached earnings event is "CAPR earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CAPR filing is 8-K · Aug 24, 2026. Filings: https://lician.com/sec/capr